Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria

@article{Niehues2004EvidencebasedUO,
  title={Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria},
  author={Tim Niehues and Gerd Horneff and Hartmut Michels and Michaela Sailer H{\"o}ck and Lothar Schuchmann},
  journal={Rheumatology International},
  year={2004},
  volume={25},
  pages={169-178}
}
Juvenile idiopathic arthritis (JIA) is the most common diagnosis in children and adolescents with rheumatic disorders. In many children and adolescents, JIA is successfully treated with non-steroidal anti-inflammatory drugs (NSAID) and physiotherapy. However, in a significant number of cases the disease is resistant to this therapy, and treatment with… CONTINUE READING